Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Companies / Oncolytics Biotech
Company

Oncolytics Biotech

Tracked across 3 events · 19 articles · First seen Jun 02, 2026 · Last active Jul 21, 2026

Sentiment
50
Attention
4
Events
3
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (3)
2 50
Business
Oncolytics Biotech appoints Glover, promotes McAdory
Impact: Oncolytics Biotech announced the appointment of Steve-O>>> to its Board of Directors and the promotion of John McAdory>>> to Chief Operating Officer, strengthening its leadership team for strategic growth and operational execution.
Jun 02, 2026 · 7 articles
4 70
Business
Oncolytics Biotech secures pelareorep patent
Impact: Oncolytics Biotech received a new patent for its pelareorep manufacturing process, strengthening its intellectual property and supporting commercialization efforts. This enhances the long-term value of its lead product.
Jun 16, 2026 · 6 articles
2 30
Regulatory
FDA Fast Track for Pelareorep in Anal Cancer
Impact: Oncolytics received its third Fast Track designation for pelareorep, strengthening its regulatory momentum and path toward registration. However, the company faces a going concern risk due to limited cash resources.
Jul 20, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Oncolytics Biotech live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.